{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:32:14Z","timestamp":1793799134616,"version":"4.6.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117421","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T15:14:12Z","timestamp":1789312452000},"page":"117421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inflammation biomarkers in cancer: mechanistic drivers, diagnostic innovations, and future clinical horizons"],"prefix":"10.1016","volume":"189","author":[{"given":"Pritam","family":"Kayal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramit","family":"Rahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apala","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princy","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya Vikram","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.117421_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.117421_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117421_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0667-0","article-title":"Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape","author":"Osipov","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117421_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050880","article-title":"Revolutionary Cancer therapy for personalization and improved efficacy: strategies to overcome resistance to immune checkpoint inhibitor therapy","author":"Almawash","year":"2025","journal-title":"Cancers"},{"issue":"7637","key":"10.1016\/j.intimp.2026.117421_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.117421_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.intimp.2026.117421_bb0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cncr.21617","article-title":"The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma","volume":"106","author":"Sengupta","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2026.117421_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-023-01073-9","article-title":"Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms","author":"Wang","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2026.117421_bb0045","article-title":"Cancer immunotherapies: from efficacy to resistance mechanisms \u2014 not only checkpoint matters","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117421_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jclinepi.2020.03.016","article-title":"Reporting scoping reviews \u2014 PRISMA ScR extension","author":"McGowan","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2026.117421_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/biology11060929","article-title":"Tumor microenvironment \u2014 a short review of cellular and interaction diversity","author":"Bo\u017cyk","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.intimp.2026.117421_bb0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s40610-017-0073-7","article-title":"Tumor microenvironment heterogeneity: challenges and opportunities","volume":"3","author":"Runa","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2026.117421_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/abbs\/gmu135","article-title":"Anti-inflammatory effect of resveratrol through the suppression of NF-\u03baB and JAK\/STAT signaling pathways","volume":"47","author":"Ma","year":"2015","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.intimp.2026.117421_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genrep.2016.01.002","article-title":"The role of JAK\/STAT signaling pathway and TNF-\u03b1 crosstalk in human colorectal cancer","volume":"3","author":"Erkasap","year":"2016","journal-title":"Gene Rep."},{"key":"10.1016\/j.intimp.2026.117421_bb0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117421_bb0080","doi-asserted-by":"crossref","unstructured":"Mohamed AH, Ahmed AT, Al Abdulmonem W, Bokov DO, Shafie A, Al-Hetty HRAK, et al. Interleukin-6 serves as a critical factor in various cancer progression and therapy. Med. Oncol. 2024. doi:https:\/\/doi.org\/10.1007\/s12032-024-02422-5 (PubMed PMID: 38900329).","DOI":"10.1007\/s12032-024-02422-5"},{"issue":"1","key":"10.1016\/j.intimp.2026.117421_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13402-022-00742-0","article-title":"TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells","volume":"46","author":"He","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.intimp.2026.117421_bb0090","doi-asserted-by":"crossref","unstructured":"Naqash AR, McCallen JD, Mi E, Iivanainen S, Marie MA, Gramenitskaya D, et al. Increased interleukin-6\/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J. Immunother. Cancer 2023 11(10):e007310. doi:https:\/\/doi.org\/10.1136\/jitc-2023-007310 (PubMed PMID: 37852738).","DOI":"10.1136\/jitc-2023-007310"},{"key":"10.1016\/j.intimp.2026.117421_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for Atheroprotection","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117421_bb0100","first-page":"1142","article-title":"Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma","volume":"7","author":"Tas","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117421_bb0105","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/cam4.5180","article-title":"Handgrip weakness, systemic inflammation indicators, and overall survival in lung cancer patients with well performance status: a large multicenter observational study","volume":"12","author":"Song","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117421_bb0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12957-025-03910-2","article-title":"Pan-immune-inflammation value in lung cancer: prognostic significance and implications for therapeutic guidance \u2014 a systematic review and meta-analysis","volume":"23","author":"Hong","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117421_bb0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12957-024-03595-z","article-title":"Pan-immune-inflammation value as a novel prognostic biomarker for digestive system cancers: a meta-analysis","volume":"22","author":"Yu","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.intimp.2026.117421_bb0120","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1073\/pnas.1821068116","article-title":"Inflammatory regulatory network mediated by the joint action of NF-\u03baB, STAT3, and AP-1 factors is involved in many human cancers","volume":"116","author":"Ji","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117421_bb0125","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/med.21761","article-title":"The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy","author":"Garg","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"10105","key":"10.1016\/j.intimp.2026.117421_bb0130","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117421_bb0135","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.7150\/thno.120259","article-title":"Development of new IL-1R antagonists with improved anti-inflammatory efficacy","volume":"16","author":"Kang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.117421_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.117421_bb0145","doi-asserted-by":"crossref","unstructured":"Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J. Clin. Lab. Anal. 2019 33(8):e22964. doi:https:\/\/doi.org\/10.1002\/jcla.22964 (PubMed PMID: 31282096).","DOI":"10.1002\/jcla.22964"},{"issue":"8","key":"10.1016\/j.intimp.2026.117421_bb0150","doi-asserted-by":"crossref","first-page":"996","DOI":"10.29271\/jcpsp.2022.08.996","article-title":"Systemic immune inflammation index as a key marker of survival and immune-related adverse events in immune checkpoint inhibitor therapy","volume":"32","author":"Ekinci","year":"2022","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.intimp.2026.117421_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12903-025-07513-x","article-title":"MMP-9 as a diagnostic salivary biomarker for early detection of oral cancers: systematic review and meta-analysis","author":"Shaukat","year":"2026","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.intimp.2026.117421_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/AIA.0000000000000509","article-title":"Perioperative immunomodulation and Cancer recurrence","author":"Villa","year":"2026","journal-title":"Int. Anesthesiol. Clin."},{"key":"10.1016\/j.intimp.2026.117421_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/jak\/STAT pathway","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2026.117421_bb0185","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/jth.14525","article-title":"Physical proximity and functional cooperation of glycoprotein 130 and glycoprotein VI in platelet membrane lipid rafts","volume":"17","author":"Houck","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2026.117421_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/imm.70103","article-title":"Bidirectional regulation in the tumour microenvironment: the interaction between tumour-associated macrophages and T cells reshapes the paradigm of Cancer immunotherapy","author":"Li","year":"2026","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2026.117421_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-025-05457-y","article-title":"Loop of N2-polarized neutrophils and exhausted CD8+ T cells induces immunotherapy resistance in NSCLC","author":"Zou","year":"2026","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2026.117421_bb0180","doi-asserted-by":"crossref","unstructured":"Li ZY, Peng SY, Li FL, Cai HQ. Immunosuppressive tumor microenvironment shape pancreatic cancer unresponsive to current immunotherapies. World J. Clin. Oncol. 2026 17:114423. doi:https:\/\/doi.org\/10.5306\/wjco.v17.i2.114423 (PubMed PMID: 41810352).","DOI":"10.5306\/wjco.v17.i2.114423"},{"key":"10.1016\/j.intimp.2026.117421_bb0190","article-title":"Tumor-associated neutrophils and desmoplastic reaction in the breast cancer tumor microenvironment: a comprehensive review","volume":"18","author":"Papadopoulou","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117421_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gtc.2025.10.002","article-title":"Biomarkers for early detection and monitoring of colorectal Cancer","volume":"55","author":"Char","year":"2026","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.intimp.2026.117421_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-01278-8","article-title":"5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer","volume":"6","author":"Puddu","year":"2026","journal-title":"Commun. Med."},{"key":"10.1016\/j.intimp.2026.117421_bb0205","doi-asserted-by":"crossref","unstructured":"Shafique K, Proctor MJ, McMillan DC, Leung H, Smith K, Sloan B, et al. The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients. BMC Cancer 2013 13:292. doi:https:\/\/doi.org\/10.1186\/1471-2407-13-292 (PubMed PMID: 23768149).","DOI":"10.1186\/1471-2407-13-292"},{"key":"10.1016\/j.intimp.2026.117421_bb0210","article-title":"High neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) are markers of longer survival after Metastasectomy of patients with liver-only metastasis of rectal Cancer","volume":"28","author":"Polk","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.intimp.2026.117421_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-026-01736-z","article-title":"Therapeutic potential of tyrosine kinase inhibitors in advanced thyroid cancer","author":"Gangadaran","year":"2026","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.intimp.2026.117421_bb0220","article-title":"IL-6: a key player in the EGFR-TKI-resistant tumor microenvironment and its therapeutic implications (review)","author":"Wei","year":"2025","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2026.117421_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/jpm16030132","article-title":"Biomarkers in colorectal cancer: clinically relevant diagnostic and prognostic molecular features, and the future of precision medicine","volume":"16","author":"Whitmer","year":"2026","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.intimp.2026.117421_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-026-09675-y","article-title":"A practical guide to targeted single-cell RNA sequencing technologies","author":"Moro","year":"2026","journal-title":"Commun. Biol."},{"key":"10.1016\/j.intimp.2026.117421_bb0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.70267\/\/lshe.20260108","article-title":"Deciphering treatment resistance in NSCLC with single-cell sequencing technology","volume":"12","author":"Li","year":"2026","journal-title":"Exploring Science Academic Conference Series."},{"key":"10.1016\/j.intimp.2026.117421_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D5AY01294E","article-title":"Data independent acquisition mass spectrometry (DIA-MS) in cancer studies: a concise review","author":"Kumar","year":"2026","journal-title":"Anal. Methods"},{"key":"10.1016\/j.intimp.2026.117421_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cyt.70031","article-title":"Beyond tissue in the era of liquid biopsy: pathologists\u2019 perspectives and insights","author":"Urso","year":"2026","journal-title":"Cytopathology"},{"key":"10.1016\/j.intimp.2026.117421_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-026-02040-7","article-title":"LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review","author":"Vanan","year":"2026","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117421_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s42047-026-00218-7","article-title":"The fundamental role of liquid biopsy in lung cancer: a shift in paradigm in the realm of thoracic oncology","volume":"9","author":"Malik","year":"2026","journal-title":"Surgical and experimental Pathology"},{"key":"10.1016\/j.intimp.2026.117421_bb0260","article-title":"AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions","author":"Hsu","year":"2026","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117421_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-025-00897-6","article-title":"Convergence of machine learning and genomics for precision oncology","author":"Reardon","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117421_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70494","article-title":"Review of existing approaches and potential role of pharmacometrics in the interpretation of prognostic circulating serum biomarkers in advanced NSCLC","author":"Ojara","year":"2026","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.intimp.2026.117421_bb0275","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-025-04194-4","article-title":"Impact of vitamin D deficiency and inflammatory biomarkers on pathological response to neoadjuvant chemotherapy in breast cancer","author":"Ba\u015fkurt","year":"2026","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.intimp.2026.117421_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/metabo16030174","article-title":"Obesity and cancer: from systemic metabolic reprogramming to immunotherapy paradox","volume":"16","author":"Han","year":"2026","journal-title":"Metabolites"},{"key":"10.1016\/j.intimp.2026.117421_bb0285","doi-asserted-by":"crossref","unstructured":"Gupta AK. Obesity, inflammation, and cancer immunotherapy: the adipose\u2013immune axis as a therapeutic frontier. International Journal of Molecular and Immuno Oncology. 2026 0:1. doi:10.25259\/IJMIO_35_2025.","DOI":"10.25259\/IJMIO_35_2025"},{"key":"10.1016\/j.intimp.2026.117421_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27062692","article-title":"Biosensor-based detection of calprotectin and lactoferrin as neutrophil-derived markers of inflammatory bowel diseases: from molecular pathophysiology to point-of-care platforms","volume":"27","author":"Sitkov","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117421_bb0295","unstructured":"Lundberg SM, Lee SI. A Unified Approach to Interpreting Model Predictions. In: Advances in Neural Information Processing Systems. 2017. (p. 4766\u201375)."},{"key":"10.1016\/j.intimp.2026.117421_bb0300","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70335","article-title":"Opioids in breast cancer: between analgesia and modulation of tumour progression","author":"Ciwun","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117421_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/mdb2.70024","article-title":"Traditional Chinese medicine as an integrative adjunct in oncology perioperative practice: analgesia, immune modulation, and translational challenges","author":"Tang","year":"2026","journal-title":"Medicine Bulletin."},{"key":"10.1016\/j.intimp.2026.117421_bb0310","doi-asserted-by":"crossref","unstructured":"Anton A, Friedman SL, Cogliati B. Hepatic fibrosis and liver Cancer. Semin. Liver Dis. 2026 doi:https:\/\/doi.org\/10.1055\/a-2779-4937 (PubMed PMID: 41468910).","DOI":"10.1055\/a-2779-4937"},{"key":"10.1016\/j.intimp.2026.117421_bb0315","article-title":"Plant-derived bioactive compounds in inflammation-related cancers: mechanisms and therapeutic potential","author":"Song","year":"2026","journal-title":"Plants"},{"key":"10.1016\/j.intimp.2026.117421_bb0320","doi-asserted-by":"crossref","unstructured":"Wang K, Li J, Li J, Zeng F, Li S, Chen P, et al. Spatiotemporal immune gradients in gout: immune response-driven activation of the NLRP3-IL-1\u03b2 axis and its transition to trained immunity. Front. Immunol. 2026;17:1776479. doi:https:\/\/doi.org\/10.3389\/fimmu.2026.1776479 (PubMed PMID: 41836392).","DOI":"10.3389\/fimmu.2026.1776479"},{"key":"10.1016\/j.intimp.2026.117421_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27062538","article-title":"Across the social network of the gut: bacterial, fungal, and viral determinants of checkpoint inhibitor efficacy and toxicity","volume":"27","author":"Antohi","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117421_bb0330","article-title":"Piezo1 as a mechanical checkpoint in T cell immunotherapy for solid tumors","author":"Cui","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117421_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031347","article-title":"Natural products targeting key molecular hallmarks in gastric Cancer: focus on apoptosis, inflammation, and chemoresistance","author":"Simancas-Racines","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117421_bb0340","article-title":"Signaling pathways and targeted interventions for precancers","author":"Yang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117421_bb0345","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-026-07928-2","article-title":"Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII)","volume":"216","author":"Guirao Garc\u00eda","year":"2026","journal-title":"Breast Cancer Res. Treat."},{"issue":"16","key":"10.1016\/j.intimp.2026.117421_bb0350","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.intimp.2026.117421_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-025-00889-6","article-title":"Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery","author":"Ansermino","year":"2026","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2026.117421_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71578","article-title":"Digital biomarkers for precision early detection of lung Cancer: integrating AI-driven multi-omics into clinical pathways","author":"Bu","year":"2026","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2026.117421_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ph19020318","article-title":"Diet and gut microbiota in inflammatory bowel disease: a clinical and nutritional perspective","author":"Bertin","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.intimp.2026.117421_bb0370","article-title":"Single-cell multi-omics for biomarker discovery: technologies, molecular mechanisms, applications and translational challenges","author":"Sahu","year":"2026","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.intimp.2026.117421_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2025.12.001","article-title":"Artificial intelligence in diagnostic, prognostic, and predictive genomic biomarkers for prostate cancer: ready for prime time?","author":"Bazarkin","year":"2026","journal-title":"Urologic Oncol.: Seminars Original Investig."},{"key":"10.1016\/j.intimp.2026.117421_bb0380","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v32.i1.111428","article-title":"Artificial intelligence and machine learning-driven advancements in gastrointestinal cancer: paving the way for precision medicine","author":"Suri","year":"2026","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2026.117421_bb0385","series-title":"Artificial Intelligence and Machine Learning in Neurology","first-page":"555","article-title":"Artificial Intelligence\u2013Driven Identification of Biomarkers for Precision Medicine Advancements Through Bioinformatics in Healthcare Applications","author":"Thamminaina","year":"2026"},{"key":"10.1016\/j.intimp.2026.117421_bb0390","doi-asserted-by":"crossref","DOI":"10.1039\/D5LC00892A","article-title":"Wearable biosensors for disease diagnostics and health monitoring: recent Progress and emerging technologies","author":"Ren","year":"2026","journal-title":"Lab Chip"},{"key":"10.1016\/j.intimp.2026.117421_bb0395","series-title":"Nanotheranostics and Precision Oncology","first-page":"609","article-title":"Biomarkers emerging in nanotheranostics and precision medicine","author":"Khan","year":"2025"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:57:13Z","timestamp":1793797033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926012683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":79,"alternative-id":["S1567576926012683"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117421","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation biomarkers in cancer: mechanistic drivers, diagnostic innovations, and future clinical horizons","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117421"}}